Streetbeat News

Stock Prices

AEMD

GOVX

INO

MRNA

SIGA

TNXP

The Africa CDC has declared Mpox a public health emergency of continental security, highlighting the urgency and potential impact of the disease on the continent.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 1:51 pm

SRZN

Surrozen shares are trading lower after the company reported worse-than-expected Q2 adjusted EPS results.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 1:50 pm

JNJ

Johnson & Johnson (NYSE:JNJ) has made significant progress in resolving lawsuits related to its baby powder allegedly causing cancer. Over 75% of plaintiffs have agreed to a $6.5 billion settlement proposal. This milestone could lead to a fast-tracked Chapter 11 bankruptcy filing to manage liabilities. Despite this progress, J&J still faces legal challenges.

Portfolio Pulse from Vandana Singh

August 13, 2024 | 1:50 pm

CMG

NVDA

SBUX

SPY

The Producer Price Index (PPI) figures came in below estimates, which could indicate easing inflation pressures. Chipotle's CEO is set to join Starbucks, and NVIDIA's stock is on the rise.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 1:45 pm

SLND

Southland Holdings reported a Q2 2024 adjusted EPS of $(0.96), which significantly missed the $0.02 estimate. Additionally, the company's sales of $251.51 million fell short of the $293.67 million estimate.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 1:44 pm

SBUX

Elliott Investment Management has expressed confidence in Starbucks following the appointment of Brian Niccol as CEO, viewing it as a transformational step forward. The firm has pledged continued engagement with Starbucks' board.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 1:43 pm

BAX

Baxter shares are trading lower after announcing a definitive agreement to divest its Vantive Kidney Care segment to Carlyle for $3.8 billion. The stock initially gained but has since reversed.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 1:42 pm

SE

Sea Limited shares are trading higher following mixed Q2 earnings.

Portfolio Pulse from Benzinga Newsdesk

August 13, 2024 | 1:41 pm

ABBV

BMY

RHHBY

SYRS

Syros Pharmaceuticals (NASDAQ:SYRS) announced the discontinuation of its SELECT-AML-1 Phase 2 trial for a leukemia treatment due to disappointing interim results. The trial compared a triplet regimen including tamibarotene, venetoclax (marketed by AbbVie Inc. and Roche Holdings AG), and azacitidine (marketed by Bristol Myers Squibb & Co) to a doublet regimen. The stock of Syros Pharmaceuticals dropped by 60.50% following the news.

Portfolio Pulse from Vandana Singh

August 13, 2024 | 1:41 pm

GLD

IWM

QQQ

SPY

TLT

A lower-than-expected Producer Price Index (PPI) report has led to increased bullish sentiment in premarket trading, with traders boosting bets on a larger Federal Reserve interest rate cut next month. Key ETFs like SPY, QQQ, IWM, and TLT saw gains, while GLD experienced a slight dip.

Portfolio Pulse from Piero Cingari

August 13, 2024 | 1:30 pm